BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1836822)

  • 1. [Paroxysmal nocturnal hemoglobinuria and GPI-anchored membrane proteins].
    Kinoshita T
    Rinsho Byori; 1991 Sep; Suppl 91():74-81. PubMed ID: 1836822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Paroxysmal nocturnal hemoglobinuria].
    Abe T; Ninomiya H
    Nihon Rinsho; 1991 Mar; 49(3):667-71. PubMed ID: 1828276
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of paroxysmal nocturnal hemoglobinuria without deficiency of decay-accelerating factor on erythrocytes.
    Oho H; Kuno Y; Tanaka H; Yamashina M; Takami T; Kondo N; Orii T
    Blood; 1990 Apr; 75(8):1746-7. PubMed ID: 1691667
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria.
    Thomas LJ; Urakaze M; DeGasperi R; Kamitani T; Sugiyama E; Chang HM; Warren CD; Yeh ET
    J Clin Invest; 1992 Apr; 89(4):1172-7. PubMed ID: 1532587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Membrane defects in paroxysmal nocturnal hemoglobinuria].
    Luzzatto L; Rotoli B
    Haematologica; 1991 Jun; 76 Suppl 3():207-12. PubMed ID: 1721602
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxysmal nocturnal hemoglobinuria and complement-mediated erythrocyte damage.
    Parker CJ
    Curr Opin Hematol; 1994 Mar; 1(2):151-6. PubMed ID: 9371274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
    Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
    Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Ware RE
    Blood; 1995 Nov; 86(9):3277-86. PubMed ID: 7579428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current theories on the pathogenesis and treatment of nocturnal paroxysmal hemoglobinuria (NPH)].
    Robak T
    Przegl Lek; 1990; 47(11):763-6. PubMed ID: 1711705
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.
    Schultz DR
    Am J Med; 1989 Sep; 87(3N):22N-29N. PubMed ID: 2484793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of phosphatidylinositol anchored membrane proteins in paroxysmal nocturnal haemoglobinuria after bone marrow transplantation.
    Perez-Oteyza J; Roldan E; Brieva JA; Cancelas JA; Garcia-Larana J; Odriozola J; Hernandez Jodra M; Navarro JL
    Bone Marrow Transplant; 1992 Sep; 10(3):297-9. PubMed ID: 1384901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria.
    Rosse WF
    Curr Top Microbiol Immunol; 1992; 178():163-73. PubMed ID: 1424773
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells.
    Szpurka H; Schade AE; Jankowska AM; Maciejewski JP
    Br J Haematol; 2008 Jul; 142(3):413-22. PubMed ID: 18544084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutation and clonal selection in the pathogenesis and in the control of paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hillmen P
    Semin Hematol; 1998 Apr; 35(2):149-67. PubMed ID: 9565157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular abnormality of paroxysmal nocturnal hemoglobinuria].
    Ueda E; Kitani T; Kinoshita T
    Nihon Naika Gakkai Zasshi; 1994 May; 83(5):840-5. PubMed ID: 7964031
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.
    Parker CJ
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):36-42. PubMed ID: 1718642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent advances in research on paroxysmal nocturnal hemoglobinuria].
    Kinoshita T
    Rinsho Ketsueki; 1993 May; 34(5):529-36. PubMed ID: 8315823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.